Article Details

AstraZeneca Withdraws Drug for Hairy Cell Leukemia From US Market - Medscape

Retrieved on: 2023-01-13 15:20:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Withdraws Drug for Hairy Cell Leukemia From US Market - Medscape. View article details on hiswai:

Excerpt

AstraZeneca has sent a letter to healthcare professionals in the United States informing them that it will be taking its leukemia drug moxetumomab ...

Article found on: www.medscape.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up